NL-OMON28744尚未招募不适用
IMProving Adherence in chronic hepatitis C patients on peg-interferon - ribavirin combination Therapy.
niversity Medical Center Utrecht (UMCU)0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. CHC patients eligible for antiviral treatment with PEG-interferon and ribavirin (PegIntron®/ Rebetol®);
- •2. 18 years of age or older;
排除标准
- •Contra-indications for antiviral treatment.
研究者
相似试验
已完成
不适用
Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)Hepatitis C, ChronicHepacivirusNCT00704522Merck Sharp & Dohme LLC601
终止
不适用
Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)Hepatitis C, ChronicHepacivirusNCT00723879Merck Sharp & Dohme LLC115
已完成
不适用
Multidisciplinary Support Program in Chronic Hepatitis CHepatitis C, ChronicNCT01850745Parc de Salut Mar447
已完成
不适用
Retreatment of chronic hepatitis C patients with pegylated interferon, ribavirin and amantadine; A pilot study to establishif initial drop in viral load is predictive for sustained virological response.Chronic hepatitis C infectionNL-OMON27702Schering-Plough61
撤回
不适用
Improving treatment adherence in chronically ill adolescents and young adults.NL-OMON46629Academisch Medisch Centrum500